Syneron Medical Ltd. (NASDAQ:ELOS) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Thursday.
Separately, Maxim Group cut shares of Syneron Medical from a “buy” rating to a “hold” rating and lowered their price target for the stock from $12.00 to $11.00 in a research report on Friday, May 12th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the stock. Syneron Medical currently has an average rating of “Hold” and a consensus target price of $9.95.
Shares of Syneron Medical (NASDAQ ELOS) remained flat at $10.95 during mid-day trading on Thursday. The stock had a trading volume of 144,434 shares. The firm’s market cap is $382.13 million. Syneron Medical has a 52 week low of $6.18 and a 52 week high of $11.43. The firm has a 50-day moving average price of $10.90 and a 200-day moving average price of $10.14.
ILLEGAL ACTIVITY WARNING: “BidaskClub Downgrades Syneron Medical Ltd. (ELOS) to Sell” was published by WKRB News and is owned by of WKRB News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.wkrb13.com/markets/2285459/bidaskclub-downgrades-syneron-medical-ltd-elos-to-sell.html.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Jane Street Group LLC raised its position in shares of Syneron Medical by 117.9% in the first quarter. Jane Street Group LLC now owns 10,373 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 68,405 shares during the last quarter. PEAK6 Investments L.P. bought a new position in shares of Syneron Medical during the first quarter worth about $111,000. Citadel Advisors LLC raised its position in shares of Syneron Medical by 2.1% in the first quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock worth $125,000 after buying an additional 243 shares during the last quarter. Two Sigma Securities LLC bought a new position in shares of Syneron Medical during the first quarter worth about $164,000. Finally, GSA Capital Partners LLP raised its position in shares of Syneron Medical by 7.9% in the fourth quarter. GSA Capital Partners LLP now owns 22,552 shares of the medical equipment provider’s stock worth $189,000 after buying an additional 1,654 shares during the last quarter. Institutional investors and hedge funds own 69.17% of the company’s stock.
Syneron Medical Company Profile
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2285459/bidaskclub-downgrades-syneron-medical-ltd-elos-to-sell.html
Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.